Work In Progress Llc | |
1055 N Randolph Rd, Randolph Center, VT 05061-9650 | |
(802) 272-8065 | |
Not Available |
Full Name | Work In Progress Llc |
---|---|
Type | Facility |
Speciality | Occupational Therapist |
Location | 1055 N Randolph Rd, Randolph Center, Vermont |
Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1477216380 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Work In Progress Llc 1055 N Randolph Rd, Randolph Center, VT 05061-9650 Ph: () - | Work In Progress Llc 1055 N Randolph Rd, Randolph Center, VT 05061-9650 Ph: (802) 272-8065 |
News Archive
Having wisdom teeth surgery can be a real pain, but if your healing regimen goes awry, you can find yourself in a world of hurt. An expert from the Texas A&M College of Dentistry explains this uncomfortable complication and how to avoid it.
Cleveland Clinic researchers Richard A. Padgett, Ph.D., and Edward F. Plow, Ph.D., have been named Fellows of the American Association for the Advancement of Science (AAAS). This year's AAAS Fellows will be formally announced in the AAAS News & Notes section of the journal Science on Nov. 29, 2013.
Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that it has demonstrated human proof-of-concept with a microRNA therapeutic from an ongoing clinical study evaluating RG-101, a wholly-owned, GalNac-conjugated anti-miR targeting microRNA-122 ("miR-122"), for the treatment of hepatitis C virus infection ("HCV").
A new study has found that although children treated for soft tissue sarcomas are surviving longer than they did in the past, they have an increased risk for second cancers, especially when initial treatment combined radiation and chemotherapy. This is according to analysis of data from the Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute.
› Verified 1 days ago